Article
Artesunate inhibits macrophage-like phenotype switching of vascular smooth muscle cells and attenuates vascular inflammatory injury in atherosclerosis via NLRP3.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Mar 2024
Liu Ping, Wang Yuqi, Tian Keke, Bai Xinyu, Wang Yaowen, Wang Yan
Abstract excerpt
Inflammation is one of the main pathogenic factors of atherosclerosis (AS), and the phenotypic transformation of macrophages in human vascular smooth muscle cells (HVSMCs) contributes to the inflammatory injury of blood vessels and the formation of atherosclerotic plaques. Artesunate reportedly exerts anti-inflammatory activity against AS. Herein, we aimed to explore the artesunate-mediated anti-inflammatory and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
